KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $255,000 | +13.8% | 13,900 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $224,000 | -33.5% | 13,900 | -42.3% | 0.00% | -33.3% |
| Q4 2021 | $337,000 | -25.8% | 24,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $454,000 | -9.6% | 24,100 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $502,000 | -26.3% | 24,100 | 0.0% | 0.00% | -42.9% |
| Q1 2021 | $681,000 | -13.5% | 24,100 | 0.0% | 0.01% | -56.2% |
| Q4 2020 | $787,000 | -12.7% | 24,100 | -18.0% | 0.02% | -23.8% |
| Q3 2020 | $901,000 | +88.1% | 29,400 | 0.0% | 0.02% | +50.0% |
| Q2 2020 | $479,000 | – | 29,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |